Study guide
2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture
NAWCCB WCC Wound Care Certified Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
About the NAWCCB WCC Exam How to Use This Study Guide
2 Assessment: Skin & Tissue Foundations
1.1 Skin Anatomy, Physiology, and Barrier Function 1.2 Phases of Wound Healing & Cellular Events 1.3 Acute vs. Chronic Wounds & Etiology Classification 1.4 TIME and MEASURE Assessment Frameworks 1.5 Wound Bed Tissue Types & Periwound Assessment 1.6 Pain Assessment: Scales, Wound Pain Types, and Procedural Analgesia 1.7 Psychosocial History, Cognitive Status, and Functional Assessment 1.8 Skin Integrity Across the Lifespan: Neonatal, Pediatric, Adult, and Geriatric
3 Assessment: Diagnostic Tools & Risk Assessment
2.1 Vascular Assessment: ABI, TcPO2, and Arterial/Venous Doppler 2.2 Neuropathy & Monofilament Testing in Diabetic Patients 2.3 Pressure Injury Risk Assessment: Braden Scale Subscales & Scoring 2.4 NPIAP Pressure Injury Staging (Stages 1-4, Unstageable, DTPI) 2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture 2.6 Laboratory Interpretation in Wound Care: Albumin, Prealbumin, ESR, A1C, CBC, and CMP 2.7 Risk Assessment Instruments Beyond Braden: Norton, Braden Q, Braden QD, Wagner, and University of Texas
4 Treatment: Dressing Selection & Debridement Modalities
3.1 Principles of Dressing Selection by Exudate & Moisture Balance 3.2 High-Absorbency Dressings: Alginates, Hydrofibers, and Foams 3.3 Barrier & Hydrating Dressings: Hydrocolloids, Transparent Films, and Hydrogels 3.4 Antimicrobial & Biofilm Dressings: Silver, Cadexomer Iodine, and Honey 3.5 Debridement Modalities: Sharp, Enzymatic, Autolytic, Mechanical, & Biosurgical
5 Treatment: Advanced Therapies & Specialized Management
4.1 Negative Pressure Wound Therapy (NPWT) Indications, Settings, & Precautions 4.2 Compression Therapy Protocols & ABI Safety Cutoffs 4.3 DFU Off-loading Hierarchy: TCC, RCW, and Therapeutic Footwear 4.4 Support Surfaces, Microclimate Control, & Repositioning Protocols 4.5 Advanced Biologics, Cellular/Tissue Products (CTPs), & HBOT
6 Reevaluation & Wound Healing Trajectory
5.1 Healing Trajectory Benchmarks & Percent Area Reduction (PAR) 5.2 Serial Wound Measurement, Depth Profiling, & Digital Photography 5.3 Treatment Plan Reassessment & Non-Healing Wound Escalation Triggers 5.4 Biofilm Progression & Systemic Infection Re-evaluation 5.5 Palliative Wound Management: Odor, Exudate, and Pain Control 5.6 Validated Healing Instruments: The PUSH Tool, BWAT, and Evaluating Adherence
7 Risk Reduction & Prevention Strategies
6.1 Pressure Injury Prevention: Bundles, Turning Schedules, & Heel Floating 6.2 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis (IAD) 6.3 Infection Control, Contact Precautions, & Environmental Hygiene 6.4 Prevention of Skin Tears & Medical Adhesive-Related Skin Injuries (MARSI) 6.5 Diabetic & Venous Ulcer Recurrence Prevention Protocols 6.6 At-Risk Populations: Spinal Cord Injury, Stroke, Critical Care, and Cognitive Impairment
8 Patient & Caregiver Education
7.1 Patient & Caregiver Wound Care Teaching & Self-Management 7.2 Diabetic Foot Self-Inspection & Footwear Education 7.3 Nutritional Assessment & Dietary Interventions for Wound Healing 7.4 Off-loading Compliance & Patient Mobility Education 7.5 Recognizing Complications, Infection Signs, & When to Seek Care 7.6 Educating the Interprofessional Team & Developing Educational Media
9 Administration & Program Management
8.1 Wound Care Documentation Standards & Clinical Records 8.2 Admission Wound Screening & Present on Admission (POA) Documentation 8.3 Interdisciplinary Team Roles & Clinical Care Coordination 8.4 Quality Improvement Metrics & HAPI Tracking Programs 8.5 Wound Care Formulary Management & Resource Utilization
10 Legal, Ethical, & Scope of Practice
9.1 Informed Consent, Treatment Refusal, & Autonomy in Wound Care 9.2 HIPAA Compliance & Clinical Photography Privacy Standards 9.3 Scope of Practice Across WCC-Eligible Professions (RN, LPN, PT, OT, DPM, MD/DO, PA) 9.4 HAPI Malpractice Liability & Documentation Defense 9.5 Ethical Considerations in Non-Healing Wounds & End-of-Life Skin Care 9.6 Regulatory Compliance, Coding Standards, & Audit Protection
2.5 Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture
Key Takeaways Explain This Topic AI
Wound exudate types include serous (clear/thin), sanguineous (red/fresh blood), serosanguineous (pink/thin), seropurulent (cloudy/yellow-pink), and purulent (thick/opaque/yellow-green/foul odor).
Biofilm is present in >78% of chronic non-healing wounds, forming a polymicrobial matrix of Extracellular Polymeric Substances (EPS) that confers 100-1000x resistance to antibiotics and antiseptics.
The NERDS framework identifies superficial wound infection/biofilm: Non-healing, Exudate increase, Red & bleeding granulation, Debris/slough, Smell. Meeting >=3 criteria indicates superficial infection requiring topical antimicrobials.
The STONEES framework identifies deep tissue/systemic infection: Size increasing, Temperature elevation, Os (exposed bone), New breakdown areas, Exudate increase, Erythema/Edema >2 cm, Smell. Meeting >=3 criteria requires systemic antibiotics plus topical care.
The gold-standard swab culturing technique is the Levine Method: cleanse wound bed with sterile normal saline, rotate swab over 1 cm2 of viable granulation tissue pressing firmly to express fluid. Culturing unwashed pus, surface exudate, or slough is contraindicated.
Last updated: August 2026
Exudate Characterization, Biofilm (NERDS/STONEES), & Wound Culture
Wound exudate reflects the metabolic and biological state of the wound bed. While normal exudate delivers essential nutrients, growth factors, and immune cells to facilitate healing, altered exudate composition or excessive volume signals persistent inflammation, elevated matrix metalloproteinases (MMPs), or microbial infection. Differentiating superficial microbial colonization and biofilm burden from deep tissue infection requires structured clinical frameworks ( NERDS and STONEES ) and proper microbiological sampling technique.
Exudate Characterization & Volume Quantification
Evaluating exudate requires documenting color, consistency, odor, and volume:
Exudate Types & Clinical Significance
Serous: Clear, light amber, thin, watery fluid. Normal during the inflammatory and proliferative phases of healing.
Sanguineous: Red, thin, watery fluid representing fresh bleeding from damaged microvasculature or over-vigorous debridement.
Serosanguineous: Light pink to pale red, thin, watery fluid. Normal finding in healthy healing wound beds.
Seropurulent: Clouded, milky, yellow-to-pink fluid. Indicates early or resolving inflammatory response / infection.
Purulent: Opaque, thick, viscous fluid ranging from yellow, green, tan, to brown. Contains dense dead leukocytes, cellular debris, and bacteria; strongly indicates wound infection.
Fibrinous: Thin or thick cloudy fluid rich in fibrin strands.
Volume Quantification Standards
None: Wound bed is dry.
Scant / Minimal: Wound bed moist; no dressing saturation (<25% of dressing capacity).
Moderate: Wound bed saturated; dressing 25% to 75% saturated.
Large / Copious: Primary dressing 100% saturated with strikethrough onto secondary dressings; requires absorbent management.
Biofilm Pathophysiology & Impact on Healing
Biofilms are present in over 78% of chronic non-healing wounds . A biofilm is a complex, polymicrobial community of microorganisms enclosed within a self-produced matrix of Extracellular Polymeric Substances (EPS) composed of polysaccharides, proteins, lipids, and extracellular DNA. Biofilm Lifecycle & Antimicrobial Resistance:
- [Planktonic Bacteria] --> [Surface Attachment] --> [EPS Matrix Secretion]
- |
- [Persistent Biofilm] <-- [Quorum Sensing & Release] <-- [Mature Biofilm Community]
- (100x - 1000x resistant to antibiotics & host immune defense)
- Key Biofilm Characteristics
Antimicrobial Resistance: The EPS shield acts as a physical and chemical barrier, conferring 100- to 1,000-fold greater resistance to systemic antibiotics, topical antiseptics, and host antibodies compared to free-floating (planktonic) bacteria.
Diagnostic Recalcitrance: Biofilms cannot be detected by standard light microscopy or routine wound swab cultures.
Chronic Inflammatory Driver: Biofilm bacteria release endotoxins and quorum-sensing molecules that continuously stimulate host neutrophils to release proteases (MMPs and elastase), destroying growth factors and keeping the wound stalled in a chronic inflammatory loop.
Clinical Diagnosis of Infection: NERDS & STONEES Frameworks
Because routine culturing cannot distinguish harmless colonizers from pathogenic biofilms, clinicians use the validated NERDS and STONEES clinical criteria (developed by Dr. R. Gary Sibbald) to guide therapy.
NERDS: Criteria for Superficial Infection & Biofilm Burden
N - Non-healing wound: Wound healing has stalled despite appropriate underlying etiology management.
E - Exudate increase: Sudden or unexplained increase in fluid production.
R - Red and bleeding granulation: Friable, dark red, hyperemic tissue that bleeds easily on contact.
D - Debris or slough: Accumulation of necrotic debris or yellow slough on the wound bed.
S - Smell / Odor: Foul odor upon dressing removal.
Clinical Rule: Meeting 3 or more NERDS criteria establishes superficial infection / high biofilm burden . Treatment requires topical antimicrobial agents (e.g., silver, cadexomer iodine, medical honey, surfactant wound cleansers) and superficial debridement.
STONEES: Criteria for Deep Tissue Infection & Systemic Spread
S - Size increasing: Wound length, width, or depth is expanding.
T - Temperature elevation: Periwound skin temperature is >1°C (>1.8°F) warmer than contralateral control skin.
O - Os (Exposed Bone): Bone is exposed or easily probeable with a sterile metal probe (positive Probe-to-Bone test).
N - New areas of breakdown: Satellite lesions or new breakdown areas adjacent to the primary wound.
E - Exudate increase: Copious purulent exudate.
E - Erythema & Edema: Periwound erythema and edema extending >2 cm beyond the wound border.
S - Smell / Odor: Pronounced, persistent foul odor.
Clinical Rule: Meeting 3 or more STONEES criteria establishes deep tissue infection / systemic invasion . Treatment mandates systemic oral or IV antibiotics PLUS topical antimicrobials and surgical/sharp debridement.
Microbiological Sampling: The Levine Technique
When clinical signs of infection (NERDS or STONEES) are present, wound culturing identifies specific bacterial species and antibiotic sensitivities. Levine Swab Culturing Method:
1. Cleanse wound bed with normal saline (remove surface colonizers).
2. Identify 1 cm^2 of CLEAN, viable granulation tissue.
3. Press swab firmly into tissue while rotating 360 degrees to express fluid.
4. Place swab into transport medium; do NOT swab pus or slough!
Step-by-Step Levine Swabbing Protocol
Wound Cleansing: Thoroughly cleanse the wound bed with sterile non-antimicrobial normal saline to remove surface exudate, topical ointments, and non-pathogenic surface colonizers.
Debridement: Remove superficial loose slough or necrotic debris.
Site Selection: Identify a 1 cm² area of clean, viable granulation tissue free of eschar or purulent pooling.
Swab Application: Press the sterile swab tip firmly into the 1 cm² target area with sufficient pressure to express fluid from deep within the viable tissue , rotating the swab 360°.
Transport: Insert the swab immediately into transport media and send to the microbiology laboratory.
Contraindicated Culturing Practices: NEVER swab unwashed surface exudate, pooling pus, slough, or necrotic tissue. Doing so cultures superficial environmental colonizers rather than true tissue pathogens, leading to inappropriate antibiotic therapy.
Diagnostic Framework Infection Location Clinical Criteria Summary Threshold for Intervention Required Primary Treatment
NERDS Superficial Wound Bed & Biofilm Non-healing, Exudate, Red friable tissue, Debris, Smell >= 3 Criteria Topical antimicrobials (silver, iodine, honey) + debridement
STONEES Deep Tissue & Systemic Invasion Size expanding, Temp elevation, Os exposed, New breakdown, Erythema >2 cm, Smell >= 3 Criteria Systemic antibiotics + topical antimicrobials + surgical debridement